Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betadine 10% + levofloxacin eye drops to reduce conjunctival bacterial colonies before cataract surgery
IRCT20190212042693N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of povidone-iodine and levofloxacin in cataract and endophthalmitis, sponsored by Shiraz University of Medical Sciences. Primary endpoint: Conjunctival bacterial colony count. Started Jan 2019; status: completed.
02
Drugs
povidone-iodinelevofloxacin
03
Conditions
cataractendophthalmitis
Beyond the preview
Go deeper on IRCT20190212042693N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190212042693N1.